ReviewBiomedicines2021

Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Breast Cancer: Looking beyond Tumoral PD-L1.

Nan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.